| Preferred Name |
Pharmacogenomics |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C20050 |
| ALT_DEFINITION |
The study of inherited variations in genes that determine and can be used to predict how an individual will respond to a drug or treatment. Science that examines inherited variations in genes that dictate drug response and explores the ways such variations can be used to predict whether a person will respond favorably, adversely, or not at all to an investigational product. The study of how a person's genes affect the way he or she responds to drugs. Pharmacogenomics is being used to learn ahead of time what the best drug or the best dose of a drug will be for a person. |
| code |
C20050 |
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C132298 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C61410 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C199649 |
| Contributing_Source |
CDISC CTRP CDISC-GLOSS |
| DEFINITION |
The investigation of variations of DNA and RNA characteristics as related to drug response. |
| DesignNote |
The term is applicable to activities such as drug discovery, drug development, and clinical practice. Drug response includes drug disposition (pharmacokinetics, PK) and drug effect (pharmacodynamics, PD). The term drug should be considered synonymous with investigational (medicinal) product, medicinal product and pharmaceutical (including vaccines and other biological products).The definition of does not include other disciplines such as proteomics and metabonomics. |
| Display_Name |
Pharmacogenomics |
| FULL_SYN |
Pharmacogenetics pharmacogenomics Pharmacogenomics PGx |
| label |
Pharmacogenomics |
| Legacy Concept Name |
Pharmacogenomics |
| Preferred_Name |
Pharmacogenomics |
| prefixIRI |
Thesaurus:C20050 |
| prefLabel |
Pharmacogenomics |
| Semantic_Type |
Occupation or Discipline |
| UMLS_CUI |
C1138555 |
| subClassOf |